Cancer incidence and mortality rates decreasing in Alberta: new data Study reveals how stress may increase risk of heart disease and strokeBrain’s amygdalar activity ‘robustly’ predicts cardiovascular events, researchers find Your patient has a lower GI bleed on ASA—Do you resume antiplatelet therapy? Study suggests balance favours resumption, to reduce cardiovascular risk Bleeding risk increased with dabigatran-statin combo Study of Ontario seniors suggests caution needed with simvastatin and lovastatin Clinical Feature: Update on managing dyslipidemia A review of the updated Canadian Cardiovascular Society guidelines for dyslipidemia management. Edoxaban (Lixiana) approved in Canada Fourth direct-acting oral anticoagulant expected to reach Canadian market in early 2017. Relative cardiovascular safety of celecoxib confirmed COX-2 inhibitor is ‘non-inferior’ to ibuprofen and naproxen, trial shows Anticoagulant antidote works Beyond statins: What you need to know about alternative lipid-lowering agents Wrist-worn heart monitors not always accurate Validation ‘imperative’ for serious clinical use, researchers say First Previous 34 35 36 37 38 Next Last
